ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA Repair Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-20V6979
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global DNA Repair Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global DNA Repair Drugs Market Research Report 2025

Code: QYRE-Auto-20V6979
Report
September 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
4SC AG
ARCAGY/ GINECO GROUP
Bristol–Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech Inc
Georgetown University
German Breast Group
GlaxoSmithKline PLC
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Johnson & Johnson

DNA Repair Drugs Market Size

The global market for DNA Repair Drugs was valued at US$ 843 million in the year 2024 and is projected to reach a revised size of US$ 2708 million by 2031, growing at a CAGR of 18.4% during the forecast period.

DNA Repair Drugs Market

DNA Repair Drugs Market

DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DNA Repair Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Repair Drugs.
The DNA Repair Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Repair Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Repair Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DNA Repair Drugs Market Report

Report Metric Details
Report Name DNA Repair Drugs Market
Accounted market size in year US$ 843 million
Forecasted market size in 2031 US$ 2708 million
CAGR 18.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • PARP Inhibitors
  • Other
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, Cambridge University Hospitals NHS Foundation Trust, Genentech, Georgetown University, German Breast Group, GlaxoSmithKline, Jiangsu Hengrui Medicine, Johnson & Johnson, Jonsson Comprehensive Cancer Center, Karyopharm Therapeutics, KuDOS Pharmaceuticals, National Health Service, National Institutes of Health, Tesaro
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of DNA Repair Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is DNA Repair Drugs Market growing?

Ans: The DNA Repair Drugs Market witnessing a CAGR of 18.4% during the forecast period 2025-2031.

What is the DNA Repair Drugs Market size in 2031?

Ans: The DNA Repair Drugs Market size in 2031 will be US$ 2708 million.

Who are the main players in the DNA Repair Drugs Market report?

Ans: The main players in the DNA Repair Drugs Market are 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, Cambridge University Hospitals NHS Foundation Trust, Genentech, Georgetown University, German Breast Group, GlaxoSmithKline, Jiangsu Hengrui Medicine, Johnson & Johnson, Jonsson Comprehensive Cancer Center, Karyopharm Therapeutics, KuDOS Pharmaceuticals, National Health Service, National Institutes of Health, Tesaro

What are the Application segmentation covered in the DNA Repair Drugs Market report?

Ans: The Applications covered in the DNA Repair Drugs Market report are Oncological, Stroke

What are the Type segmentation covered in the DNA Repair Drugs Market report?

Ans: The Types covered in the DNA Repair Drugs Market report are PARP Inhibitors, Other

Recommended Reports

Genomics Therapies

Cancer Treatment

Autoimmune Diseases

1 DNA Repair Drugs Market Overview
1.1 Product Definition
1.2 DNA Repair Drugs by Type
1.2.1 Global DNA Repair Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 PARP Inhibitors
1.2.3 Other
1.3 DNA Repair Drugs by Application
1.3.1 Global DNA Repair Drugs Market Value by Application (2024 VS 2031)
1.3.2 Oncological
1.3.3 Stroke
1.4 Global DNA Repair Drugs Market Size Estimates and Forecasts
1.4.1 Global DNA Repair Drugs Revenue 2020-2031
1.4.2 Global DNA Repair Drugs Sales 2020-2031
1.4.3 Global DNA Repair Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 DNA Repair Drugs Market Competition by Manufacturers
2.1 Global DNA Repair Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global DNA Repair Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of DNA Repair Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DNA Repair Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DNA Repair Drugs, Product Type & Application
2.7 Global Key Manufacturers of DNA Repair Drugs, Date of Enter into This Industry
2.8 Global DNA Repair Drugs Market Competitive Situation and Trends
2.8.1 Global DNA Repair Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest DNA Repair Drugs Players Market Share by Revenue
2.8.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DNA Repair Drugs Market Scenario by Region
3.1 Global DNA Repair Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global DNA Repair Drugs Sales by Region: 2020-2031
3.2.1 Global DNA Repair Drugs Sales by Region: 2020-2025
3.2.2 Global DNA Repair Drugs Sales by Region: 2026-2031
3.3 Global DNA Repair Drugs Revenue by Region: 2020-2031
3.3.1 Global DNA Repair Drugs Revenue by Region: 2020-2025
3.3.2 Global DNA Repair Drugs Revenue by Region: 2026-2031
3.4 North America DNA Repair Drugs Market Facts & Figures by Country
3.4.1 North America DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America DNA Repair Drugs Sales by Country (2020-2031)
3.4.3 North America DNA Repair Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe DNA Repair Drugs Market Facts & Figures by Country
3.5.1 Europe DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe DNA Repair Drugs Sales by Country (2020-2031)
3.5.3 Europe DNA Repair Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DNA Repair Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific DNA Repair Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific DNA Repair Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific DNA Repair Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America DNA Repair Drugs Market Facts & Figures by Country
3.7.1 Latin America DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America DNA Repair Drugs Sales by Country (2020-2031)
3.7.3 Latin America DNA Repair Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa DNA Repair Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa DNA Repair Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa DNA Repair Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global DNA Repair Drugs Sales by Type (2020-2031)
4.1.1 Global DNA Repair Drugs Sales by Type (2020-2025)
4.1.2 Global DNA Repair Drugs Sales by Type (2026-2031)
4.1.3 Global DNA Repair Drugs Sales Market Share by Type (2020-2031)
4.2 Global DNA Repair Drugs Revenue by Type (2020-2031)
4.2.1 Global DNA Repair Drugs Revenue by Type (2020-2025)
4.2.2 Global DNA Repair Drugs Revenue by Type (2026-2031)
4.2.3 Global DNA Repair Drugs Revenue Market Share by Type (2020-2031)
4.3 Global DNA Repair Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global DNA Repair Drugs Sales by Application (2020-2031)
5.1.1 Global DNA Repair Drugs Sales by Application (2020-2025)
5.1.2 Global DNA Repair Drugs Sales by Application (2026-2031)
5.1.3 Global DNA Repair Drugs Sales Market Share by Application (2020-2031)
5.2 Global DNA Repair Drugs Revenue by Application (2020-2031)
5.2.1 Global DNA Repair Drugs Revenue by Application (2020-2025)
5.2.2 Global DNA Repair Drugs Revenue by Application (2026-2031)
5.2.3 Global DNA Repair Drugs Revenue Market Share by Application (2020-2031)
5.3 Global DNA Repair Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 4SC AG
6.1.1 4SC AG Company Information
6.1.2 4SC AG Description and Business Overview
6.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 4SC AG DNA Repair Drugs Product Portfolio
6.1.5 4SC AG Recent Developments/Updates
6.2 ARCAGY/ GINECO GROUP
6.2.1 ARCAGY/ GINECO GROUP Company Information
6.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
6.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
6.2.5 ARCAGY/ GINECO GROUP Recent Developments/Updates
6.3 Bristol Myers Squibb
6.3.1 Bristol Myers Squibb Company Information
6.3.2 Bristol Myers Squibb Description and Business Overview
6.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
6.3.5 Bristol Myers Squibb Recent Developments/Updates
6.4 British Columbia Cancer Agency
6.4.1 British Columbia Cancer Agency Company Information
6.4.2 British Columbia Cancer Agency Description and Business Overview
6.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
6.4.5 British Columbia Cancer Agency Recent Developments/Updates
6.5 Cambridge University Hospitals NHS Foundation Trust
6.5.1 Cambridge University Hospitals NHS Foundation Trust Company Information
6.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
6.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
6.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments/Updates
6.6 Genentech
6.6.1 Genentech Company Information
6.6.2 Genentech Description and Business Overview
6.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Genentech DNA Repair Drugs Product Portfolio
6.6.5 Genentech Recent Developments/Updates
6.7 Georgetown University
6.7.1 Georgetown University Company Information
6.7.2 Georgetown University Description and Business Overview
6.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Georgetown University DNA Repair Drugs Product Portfolio
6.7.5 Georgetown University Recent Developments/Updates
6.8 German Breast Group
6.8.1 German Breast Group Company Information
6.8.2 German Breast Group Description and Business Overview
6.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 German Breast Group DNA Repair Drugs Product Portfolio
6.8.5 German Breast Group Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Company Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Company Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Company Information
6.11.2 Johnson & Johnson Description and Business Overview
6.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Jonsson Comprehensive Cancer Center
6.12.1 Jonsson Comprehensive Cancer Center Company Information
6.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
6.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
6.12.5 Jonsson Comprehensive Cancer Center Recent Developments/Updates
6.13 Karyopharm Therapeutics
6.13.1 Karyopharm Therapeutics Company Information
6.13.2 Karyopharm Therapeutics Description and Business Overview
6.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
6.13.5 Karyopharm Therapeutics Recent Developments/Updates
6.14 KuDOS Pharmaceuticals
6.14.1 KuDOS Pharmaceuticals Company Information
6.14.2 KuDOS Pharmaceuticals Description and Business Overview
6.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
6.14.5 KuDOS Pharmaceuticals Recent Developments/Updates
6.15 National Health Service
6.15.1 National Health Service Company Information
6.15.2 National Health Service Description and Business Overview
6.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 National Health Service DNA Repair Drugs Product Portfolio
6.15.5 National Health Service Recent Developments/Updates
6.16 National Institutes of Health
6.16.1 National Institutes of Health Company Information
6.16.2 National Institutes of Health Description and Business Overview
6.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 National Institutes of Health DNA Repair Drugs Product Portfolio
6.16.5 National Institutes of Health Recent Developments/Updates
6.17 Tesaro
6.17.1 Tesaro Company Information
6.17.2 Tesaro Description and Business Overview
6.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Tesaro DNA Repair Drugs Product Portfolio
6.17.5 Tesaro Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DNA Repair Drugs Industry Chain Analysis
7.2 DNA Repair Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DNA Repair Drugs Production Mode & Process Analysis
7.4 DNA Repair Drugs Sales and Marketing
7.4.1 DNA Repair Drugs Sales Channels
7.4.2 DNA Repair Drugs Distributors
7.5 DNA Repair Drugs Customer Analysis
8 DNA Repair Drugs Market Dynamics
8.1 DNA Repair Drugs Industry Trends
8.2 DNA Repair Drugs Market Drivers
8.3 DNA Repair Drugs Market Challenges
8.4 DNA Repair Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
4SC AG
ARCAGY/ GINECO GROUP
Bristol–Myers Squibb
British Columbia Cancer Agency
Cambridge University Hospitals NHS Foundation Trust
Genentech Inc
Georgetown University
German Breast Group
GlaxoSmithKline PLC
Jiangsu Hengrui Medicine
Johnson & Johnson
Jonsson Comprehensive Cancer Center
Karyopharm Therapeutics
KuDOS Pharmaceuticals
National Health Service
National Institutes of Health
Tesaro
Johnson & Johnson
List of Tables
 Table 1. Global DNA Repair Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global DNA Repair Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global DNA Repair Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global DNA Repair Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global DNA Repair Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global DNA Repair Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global DNA Repair Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market DNA Repair Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of DNA Repair Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of DNA Repair Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of DNA Repair Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of DNA Repair Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global DNA Repair Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global DNA Repair Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global DNA Repair Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global DNA Repair Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global DNA Repair Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global DNA Repair Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global DNA Repair Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global DNA Repair Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global DNA Repair Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific DNA Repair Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific DNA Repair Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific DNA Repair Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific DNA Repair Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific DNA Repair Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa DNA Repair Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa DNA Repair Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa DNA Repair Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa DNA Repair Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa DNA Repair Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global DNA Repair Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global DNA Repair Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global DNA Repair Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global DNA Repair Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global DNA Repair Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global DNA Repair Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global DNA Repair Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global DNA Repair Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global DNA Repair Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global DNA Repair Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global DNA Repair Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global DNA Repair Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global DNA Repair Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global DNA Repair Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global DNA Repair Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global DNA Repair Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global DNA Repair Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global DNA Repair Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global DNA Repair Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global DNA Repair Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. 4SC AG Company Information
 Table 71. 4SC AG Description and Business Overview
 Table 72. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. 4SC AG DNA Repair Drugs Product
 Table 74. 4SC AG Recent Developments/Updates
 Table 75. ARCAGY/ GINECO GROUP Company Information
 Table 76. ARCAGY/ GINECO GROUP Description and Business Overview
 Table 77. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. ARCAGY/ GINECO GROUP DNA Repair Drugs Product
 Table 79. ARCAGY/ GINECO GROUP Recent Developments/Updates
 Table 80. Bristol Myers Squibb Company Information
 Table 81. Bristol Myers Squibb Description and Business Overview
 Table 82. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Bristol Myers Squibb DNA Repair Drugs Product
 Table 84. Bristol Myers Squibb Recent Developments/Updates
 Table 85. British Columbia Cancer Agency Company Information
 Table 86. British Columbia Cancer Agency Description and Business Overview
 Table 87. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. British Columbia Cancer Agency DNA Repair Drugs Product
 Table 89. British Columbia Cancer Agency Recent Developments/Updates
 Table 90. Cambridge University Hospitals NHS Foundation Trust Company Information
 Table 91. Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
 Table 92. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product
 Table 94. Cambridge University Hospitals NHS Foundation Trust Recent Developments/Updates
 Table 95. Genentech Company Information
 Table 96. Genentech Description and Business Overview
 Table 97. Genentech DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Genentech DNA Repair Drugs Product
 Table 99. Genentech Recent Developments/Updates
 Table 100. Georgetown University Company Information
 Table 101. Georgetown University Description and Business Overview
 Table 102. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Georgetown University DNA Repair Drugs Product
 Table 104. Georgetown University Recent Developments/Updates
 Table 105. German Breast Group Company Information
 Table 106. German Breast Group Description and Business Overview
 Table 107. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. German Breast Group DNA Repair Drugs Product
 Table 109. German Breast Group Recent Developments/Updates
 Table 110. GlaxoSmithKline Company Information
 Table 111. GlaxoSmithKline Description and Business Overview
 Table 112. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline DNA Repair Drugs Product
 Table 114. GlaxoSmithKline Recent Developments/Updates
 Table 115. Jiangsu Hengrui Medicine Company Information
 Table 116. Jiangsu Hengrui Medicine Description and Business Overview
 Table 117. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Jiangsu Hengrui Medicine DNA Repair Drugs Product
 Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 120. Johnson & Johnson Company Information
 Table 121. Johnson & Johnson Description and Business Overview
 Table 122. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Johnson & Johnson DNA Repair Drugs Product
 Table 124. Johnson & Johnson Recent Developments/Updates
 Table 125. Jonsson Comprehensive Cancer Center Company Information
 Table 126. Jonsson Comprehensive Cancer Center Description and Business Overview
 Table 127. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product
 Table 129. Jonsson Comprehensive Cancer Center Recent Developments/Updates
 Table 130. Karyopharm Therapeutics Company Information
 Table 131. Karyopharm Therapeutics Description and Business Overview
 Table 132. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Karyopharm Therapeutics DNA Repair Drugs Product
 Table 134. Karyopharm Therapeutics Recent Developments/Updates
 Table 135. KuDOS Pharmaceuticals Company Information
 Table 136. KuDOS Pharmaceuticals Description and Business Overview
 Table 137. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. KuDOS Pharmaceuticals DNA Repair Drugs Product
 Table 139. KuDOS Pharmaceuticals Recent Developments/Updates
 Table 140. National Health Service Company Information
 Table 141. National Health Service Description and Business Overview
 Table 142. National Health Service DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. National Health Service DNA Repair Drugs Product
 Table 144. National Health Service Recent Developments/Updates
 Table 145. National Institutes of Health Company Information
 Table 146. National Institutes of Health Description and Business Overview
 Table 147. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. National Institutes of Health DNA Repair Drugs Product
 Table 149. National Institutes of Health Recent Developments/Updates
 Table 150. Tesaro Company Information
 Table 151. Tesaro Description and Business Overview
 Table 152. Tesaro DNA Repair Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Tesaro DNA Repair Drugs Product
 Table 154. Tesaro Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. DNA Repair Drugs Distributors List
 Table 158. DNA Repair Drugs Customers List
 Table 159. DNA Repair Drugs Market Trends
 Table 160. DNA Repair Drugs Market Drivers
 Table 161. DNA Repair Drugs Market Challenges
 Table 162. DNA Repair Drugs Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of DNA Repair Drugs
 Figure 2. Global DNA Repair Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DNA Repair Drugs Market Share by Type: 2024 & 2031
 Figure 4. PARP Inhibitors Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global DNA Repair Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global DNA Repair Drugs Market Share by Application: 2024 & 2031
 Figure 8. Oncological
 Figure 9. Stroke
 Figure 10. Global DNA Repair Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global DNA Repair Drugs Market Size (2020-2031) & (US$ Million)
 Figure 12. Global DNA Repair Drugs Sales (2020-2031) & (K Units)
 Figure 13. Global DNA Repair Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 14. DNA Repair Drugs Report Years Considered
 Figure 15. DNA Repair Drugs Sales Share by Manufacturers in 2024
 Figure 16. Global DNA Repair Drugs Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest DNA Repair Drugs Players: Market Share by Revenue in DNA Repair Drugs in 2024
 Figure 18. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global DNA Repair Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America DNA Repair Drugs Sales Market Share by Country (2020-2031)
 Figure 21. North America DNA Repair Drugs Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe DNA Repair Drugs Sales Market Share by Country (2020-2031)
 Figure 25. Europe DNA Repair Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. Germany DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific DNA Repair Drugs Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific DNA Repair Drugs Revenue Market Share by Region (2020-2031)
 Figure 33. China DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America DNA Repair Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America DNA Repair Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa DNA Repair Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E DNA Repair Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of DNA Repair Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of DNA Repair Drugs by Type (2020-2031)
 Figure 55. Global DNA Repair Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of DNA Repair Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of DNA Repair Drugs by Application (2020-2031)
 Figure 58. Global DNA Repair Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 59. DNA Repair Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Targeting DNA Repair Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostate Cancer PARP Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DNA Repair Proteins And Reagents Market Research Report 2024
DNA Repair PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Drug based on PARP Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Editing Drug Market Research Report 2024
DNA Damage Response Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
PARP Inhibitors for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PARP Poly ADP ribose Polymerase Inhibitors Market Insights Forecast to 2030
Prime Editing Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acid based Therapy Market Research Report 2024
Global Nucleic acid based Therapeutics Drug Market Research Report 2024
Global Nucleic Acid Therapeutic Market Research Report 2024
DNA Repair Allkylating Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA based Therapeutics Drug Market Research Report 2024
Global DNA Medicine Based on DNA Modification Market Research Report 2025
Global Subsea Production and Processing Systems Market Insights Forecast to 2030
Global Gene Therapy For Cancer Market Research Report 2024
Global Gene Editing Tools Market Insights Forecast to 2030
Global DNA Modifying Agents Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions